Nonetheless, further research to develop this multi-bioactive compound will require distinguishing the structural relationship between NF-κB inhibition, anti-cancer, and antimicrobial effects in order to overcome toxicity and cross-reaction side effects. Here, NFKB1 is linked to cancer.